Drug profile · INN
influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
FLUCELVAX
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) (FLUCELVAX) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antiinfectives for systemic use (J07) J07BB02
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
- Class
- Antiinfectives for systemic use (J07)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) (FLUCELVAX) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Brand FLUCELVAX
Therapeutic class Antiinfectives for systemic use (J07)
ATC code J07BB02
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is influenza vaccine (surface antigen, inactivated, prepared in cell cultures)?
influenza vaccine (surface antigen, inactivated, prepared in cell cultures) (FLUCELVAX) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for influenza vaccine (surface antigen, inactivated, prepared in cell cultures)?
FLUCELVAX is a marketed brand name for influenza vaccine (surface antigen, inactivated, prepared in cell cultures). Check FDA Drugs@FDA for the current US label holder and prescribing information.